Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2026-01-02 @ 4:15 AM
Study NCT ID:
NCT00284804
Status:
COMPLETED
Last Update Posted:
2015-10-12
First Post:
2006-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MDX060-05/05E
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None